普洛药业：公司产品注射用丁二磺酸腺苷蛋氨酸拟中选本次集中采购

Group 1 - Prolo Pharmaceutical's subsidiary, Zhejiang Prolo Kangyu Pharmaceutical Co., Ltd., participated in the 11th national centralized drug procurement organized by the National Organization for Drug Procurement Office, with its product, injection adenosine methionine bisulfate, expected to be selected for this procurement [1] - For the first half of 2025, Prolo Pharmaceutical's revenue composition is projected to be 99.6% from the pharmaceutical industry and 0.4% from other businesses [1] - As of the report date, Prolo Pharmaceutical has a market capitalization of 17.9 billion yuan [1]